September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Transcorneal electrical stimulation for the treatment of retinitis pigmentosa – Results from the TESOLAUK trial
Author Affiliations & Notes
  • Siegfried Karl Wagner
    Nuffield Laboratory of Ophthalmology, University of Oxford, London, United Kingdom
    Moorfields Eye Hospital , London, United Kingdom
  • Jasleen Jolly
    Nuffield Laboratory of Ophthalmology, University of Oxford, London, United Kingdom
    Moorfields Eye Hospital , London, United Kingdom
  • Maria Pefkianaki
    Moorfields Eye Hospital , London, United Kingdom
  • Florian Gekeler
    Department für Augenheilkunde, University of Tuebingen, Tuebingen, Germany
    Klinikum Stuttgart, Stuttgart, Germany
  • Andrew Webster
    Moorfields Eye Hospital , London, United Kingdom
  • Susan Downes
    Nuffield Laboratory of Ophthalmology, University of Oxford, London, United Kingdom
    The Oxford Eye Hospital, Oxford, United Kingdom
  • Robert Maclaren
    Nuffield Laboratory of Ophthalmology, University of Oxford, London, United Kingdom
    The Oxford Eye Hospital, Oxford, United Kingdom
  • Footnotes
    Commercial Relationships   Siegfried Wagner, None; Jasleen Jolly, None; Maria Pefkianaki, None; Florian Gekeler, None; Andrew Webster, None; Susan Downes, None; Robert Maclaren, None
  • Footnotes
    Support  NIHR Portfolio sudy (ID14217); Oxford Biomedical Research Centre HJRWAC04.HM00; Okuvision Grant
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Siegfried Karl Wagner, Jasleen Jolly, Maria Pefkianaki, Florian Gekeler, Andrew Webster, Susan Downes, Robert Maclaren; Transcorneal electrical stimulation for the treatment of retinitis pigmentosa – Results from the TESOLAUK trial. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : Transcorneal electrical stimulation (TES) may rescue axotomized retinal ganglion cells through upregulation of endogenous neurotrophic factors. An initial pilot study assessing TES in participants with retinitis pigmentosa (RP) identified improvements in kinetic perimetry and scotopic electroretinography function. We report the results of the TESOLAUK study, which explored the impact and safety of TES in participants with RP.

Methods : Fourteen trial participants, aged 18 – 79 with confirmed rod-cone dystrophy were recruited at two university hospitals into an open-label observational trial for one year (NCT01847365). Participants with other ocular diseases were excluded as part of the protocol. Assessments occurred at baseline and each three months thereafter. Each assessment visit incorporated slit lamp examination, applanation tonometry, optical coherence tomography (OCT) and autofluorescence. Visual function was assessed with Goldmann visual fields (GVF) and microperimetry (MP). Weekly TES was administered by the Okustim® device for six months to one eye. The current administered was 150% of the threshold upon which the individual first perceived central phosphenes (individual phosphene threshold, IPT).

Results : All participants tolerated TES well with no serious adverse effects noted. Two of fourteen participants withdrew from the study due to personal reasons during the observation period. After six months of TES, mean change in 10-2 MP threshold sensitivity was +0.02±1.93 dB for the control and +0.37±1.53 dB for the treated eye (p=0.61). Mean GVF volumes were +0.16±0.32 steradians for the control and +0.22±0.45 for the treated eye steradians (p=0.66).

Conclusions : TES demonstrated a favorable side effect profile with the most common adverse effect being a transient foreign body sensation and ocular irritation. Although there was a numerical increase in both GVF and MP, it was not statistically significant. Subsequent studies should investigate the impact of TES in specific RP genotypes, its impact over a longer period and whether adjustment of the delivered current may promote improvement.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×